Arthur Rascon brings over two decades of experience in operational leadership and a proven track record of driving innovation and commercialization in the medical device industry. Prior to joining StimAire, Arthur Rascon served as the Chief Executive Officer at Valencia Technologies Corporation, where he led the company’s neuromodulation therapies. He has extensive experience in medical product development, manufacturing process optimization and operational management.

Tarek Makansi, PhD Electrical Engineering is StimAire’s founder and the inventor of the fundamental technology that enables the injectability of a neurostimulator activated by a magnetic field. Earlier, Tarek founded Tempronics, which was sold to a Fortune 500 company. Prior to that, Tarek had a 20-year career at IBM, including a role as Director of Worldwide Product Strategy for the multi-billion-dollar data storage unit.

Dan Root, MD co-developed the user interface and the titration procedure for the StimAire neuromodulator for treating Obstructive Sleep Apnea. Dan is the founder of Oregon Sleep Associates, a sleep medicine facility and sleep laboratory in Portland, Oregon. His experience treating thousands of OSA patients led him to recognize key gaps in the treatment market, which he hopes to close with StimAire. Dan also founded a company hosting an online store for sleep apnea patients which was sold in 2017.

Robert Dean PhD, MD/ENT developed the injection procedure for the StimAire neurostimulator device for treating Obstructive Sleep Apnea. Robert is CEO of Urgent Specialists, was been President of Tucson ENT, and is an active member of the American Academy of Otolaryngology.

Abhay Sanan, MD practiced for 24 years at the Center for Neurosciences, the largest in Southern Arizona focused on neurological disorders. Abhay serves as an Assistant Professor of both Neurosurgery and Radiation Oncology at the University of Arizona.

Tony Arnold is Board Member and an Independent Director for StimAire. Tony has a seasoned career as CEO of venture-backed neuromodulation companies, including SetPoint Medical in Valencia, California. Previously, Tony was an executive with Boston Scientific.

Fiona Bailey is a professor of physiology and speech/language and hearing at the University of Arizona, specializing in sleep and sleep-disordered breathing, specifically obstructive sleep apnea.

Andy Fuglevand is a professor of physiology, neurosciences and biomedical engineering at the University of Arizona, focused on research about how the nervous system controls muscles to produce coordinated movements.